Giovanni Amabile
Entrepreneur In Residence
Giovanni has demonstrated an ability to develop and advance new therapeutics from early discovery to the clinical development, with a successful track record of Marketing Authorization approvals in the US and Investigational New Drug approvals for novel molecules. Giovanni served as CSO of the swiss biotech ADIENNE Pharma & Biotech SA where he was responsible for all pre-clinical and clinical research programmes. More recently, Giovanni served as CEO of Enthera Pharmaceuticals where he has been the first employee and led a record Series A fundraising in Italy (35M Euros). For his achievements in 2021 , he has been named by the magazine Fortune Italia businessperson of the year
